Glenmede Trust CO Na Vericel Corp Transaction History

Glenmede Trust CO Na

$19.1 Billion
Q4 2024

A detailed history of Glenmede Trust CO Na transactions in Vericel Corp stock. As of the latest transaction made, Glenmede Trust CO Na holds 10,882 shares of VCEL stock, worth $448,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,882

Previous 11,363 4.23%

Holding current value

$448,664

Previous $480,000 24.38%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$40.05 - $59.11 $19,264 - $28,431	-481 Reduced 4.23%	10,882 $597,000
Q3 2024 Nov 13, 2024	BUY	$42.25 - $53.56 $4,563 - $5,784	108 Added 0.96%	11,363 $480,000
Q2 2024 Aug 14, 2024	SELL	$41.71 - $52.9 $62,356 - $79,085	-1,495 Reduced 11.73%	11,255 $516,000
Q1 2024 May 15, 2024	BUY	$32.52 - $52.33 $38,828 - $62,482	1,194 Added 10.33%	12,750 $663,000
Q4 2023 Feb 13, 2024	SELL	$30.85 - $37.09 $617 - $741	-20 Reduced 0.17%	11,556 $411,000
Q3 2023 Nov 14, 2023	SELL	$31.69 - $39.25 $7,161 - $8,870	-226 Reduced 1.91%	11,576 $388,000
Q1 2023 May 15, 2023	SELL	$23.85 - $31.34 $6,678 - $8,775	-280 Reduced 2.32%	11,802 $346,000
Q4 2022 Feb 14, 2023	SELL	$17.65 - $27.37 $882 - $1,368	-50 Reduced 0.41%	12,082 $318,000
Q3 2022 Nov 16, 2022	SELL	$22.62 - $32.54 $4,026 - $5,792	-178 Reduced 1.45%	12,132 $281,000
Q2 2022 Aug 15, 2022	SELL	$22.88 - $39.45 $34,091 - $58,780	-1,490 Reduced 10.8%	12,310 $309,000
Q1 2022 May 16, 2022	BUY	$31.69 - $43.29 $212,956 - $290,908	6,720 Added 94.92%	13,800 $527,000
Q4 2021 Feb 15, 2022	SELL	$35.2 - $52.6 $130,028 - $194,304	-3,694 Reduced 34.29%	7,080 $278,000
Q3 2021 Nov 15, 2021	BUY	$46.35 - $59.75 $227,439 - $293,193	4,907 Added 83.64%	10,774 $525,000
Q2 2021 Aug 16, 2021	BUY	$47.2 - $67.81 $276,922 - $397,841	5,867 New	5,867 $308,000

Others Institutions Holding VCEL

# of Institutions

289

Shares Held

49.6M

Call Options Held

98.2K

Put Options Held

135K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.95B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Vericel Corp Transaction History